In the latest clov stock price forecast, Fibonacci retracement levels position resistance at $1.58 and deep support at $1. A company’s long-term sales performance is one signal of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, Clover Health grew its sales at an excellent 24.3% compounded annual growth rate. Its growth beat the average healthcare company and shows its offerings resonate with customers. The most recent analyst rating on (CLOV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page . Wall Street analysts have updated their clov stock price forecast following improved revenue guidance. The revised short-term target stands at $1.65, assuming macroeconomic conditions remain favorable for health insurance providers.